{"id":9214,"date":"2025-11-15T09:26:46","date_gmt":"2025-11-15T06:26:46","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9214"},"modified":"2025-11-15T09:26:46","modified_gmt":"2025-11-15T06:26:46","slug":"national-heart-failure-registry-nhfr-jo-data-entry-form-core-fields-2","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/national-heart-failure-registry-nhfr-jo-data-entry-form-core-fields-2\/","title":{"rendered":"National Heart Failure Registry (NHFR-JO) \u2013 Data Entry Form (Core Fields)"},"content":{"rendered":"
National Heart Failure Registry (NHFR-JO) \u2013 Data Entry Form (Core Fields)<\/div>\n
<\/div>\n
National Heart Failure Transplantation Taskforce -JCS<\/div>\n
<\/div>\n
\u20071.\u2060 \u2060Patient Identification<\/div>\n
\u2022 Registry ID<\/span><\/div>\n
\u2022 Hospital \/ Center Name<\/span><\/div>\n
\u2022 Admission Number<\/span><\/div>\n
\u2022 Date of Admission \/ Date of Discharge<\/span><\/div>\n
<\/div>\n
\u20072.\u2060 \u2060Demographics<\/div>\n
\u2022 Age (years)<\/span><\/div>\n
\u2022 Sex (M \/ F)<\/span><\/div>\n
\u2022 Nationality \/ Residency<\/span><\/div>\n
\u2022 Smoking Status (Current \/ Former \/ Never)<\/span><\/div>\n
\u2022 Weight in Kg \/ Body Mass Index (BMI)<\/span><\/div>\n
<\/div>\n
\u20073.\u2060 \u2060Clinical Classification<\/div>\n
\u2022 Heart-Failure Type: Chronic \/ Acute-on-Chronic \/ De Novo(De Novo HF: first-time heart-failure presentation (\u2248 11 % in JoHFR), most often precipitated by acute myocardial infarction (MI) or myocarditis.)<\/span><\/div>\n
\u2022 LVEF (%) \u2192 HFrEF (\u2264 40 %) \/ HFmrEF (41\u201349 %) \/ HFpEF (\u2265 50 %)<\/span><\/div>\n
\u2022 Etiology: Ischemic \/ Hypertensive \/ Valvular \/ Dilated \/ Other<\/span><\/div>\n
<\/div>\n
\u20074.\u2060 \u2060Comorbidities (Checkbox)<\/div>\n
<\/div>\n
Hypertension \/ Diabetes \/ Coronary Artery Disease \/ CKD \/ COPD \/ Stroke \/ AF \/ Obesity \/ Anemia \/ Other<\/div>\n
<\/div>\n
\u20075.\u2060 \u2060Presentation & Vitals<\/div>\n
\u2022 Dyspnea (Y\/N)\u2003Orthopnea (Y\/N)\u2003PND (Y\/N)\u2003Chest Pain (Y\/N)<\/span><\/div>\n
\u2022 SBP \/ DBP\u2003HR\u2003O\u2082 Sat %\u2003NYHA Class (I\u2013IV)<\/span><\/div>\n
<\/div>\n
\u20076.\u2060 \u2060Key Labs (First 24 h)<\/div>\n
\u2022 BNP \/ NT-proBNP<\/span><\/div>\n
\u2022 Creatinine mg\/dL\u2003eGFR mL\/min\/1.73 m\u00b2<\/span><\/div>\n
\u2022 Sodium mmol\/L\u2003Potassium mmol\/L<\/span><\/div>\n
\u2022 Hemoglobin g\/dL\u2003Ferritin ng\/mL<\/span><\/div>\n
<\/div>\n
\u20077.\u2060 \u2060Echocardiography<\/div>\n
\u2022 LVEF %\u2003LVEDD mm\u2003E\/e\u2032\u2003MR grade\u2003PASP mmHg<\/span><\/div>\n
<\/div>\n
\u20078.\u2060 \u2060Medications (Guideline-Directed Medical Therapy \u2013 GDMT)<\/div>\n
\u2022 ACEI \/ ARB \/ ARNI<\/span><\/div>\n
\u2022 Prescribed: Yes \/ No<\/span><\/div>\n
\u2022 Action: Start \/ Continue \/ Contraindicated<\/span><\/div>\n
\u2022 Notes: specify reason if not prescribed (renal function, hypotension, cost, etc.)<\/span><\/div>\n
\u2022 Beta-Blocker<\/span><\/div>\n
\u2022 Prescribed: Yes \/ No<\/span><\/div>\n
\u2022 Action: Start \/ Continue \/ Hold if low BP or bradycardia<\/span><\/div>\n
\u2022 Notes: indicate specific agent if available (e.g., bisoprolol, carvedilol, metoprolol succinate)<\/span><\/div>\n
\u2022 Mineralocorticoid Receptor Antagonist (MRA)<\/span><\/div>\n
\u2022 Prescribed: Yes \/ No<\/span><\/div>\n
\u2022 Action: Start \/ Continue \/ Contraindicated<\/span><\/div>\n
\u2022 Notes: specify serum K\u207a and eGFR for eligibility<\/span><\/div>\n
\u2022 SGLT2 Inhibitor<\/span><\/div>\n
\u2022 Prescribed: Yes \/ No<\/span><\/div>\n
\u2022 Action: Start \/ Continue \/ Not Available \/ Cost Barrier<\/span><\/div>\n
\u2022 Notes: applicable for both HFrEF and HFpEF categories<\/span><\/div>\n
\u2022 Loop Diuretic<\/span><\/div>\n
\u2022 Prescribed: Yes \/ No<\/span><\/div>\n
\u2022 Form: IV \/ Oral \/ Not Used<\/span><\/div>\n
\u2022 Notes: record dose and frequency (e.g., furosemide 40 mg BID)<\/span><\/div>\n
<\/div>\n
Additional Notes:<\/div>\n
\u2022 Indicate dose and titration status where applicable.<\/span><\/div>\n
\u2022 Document contraindication reasons explicitly (renal dysfunction, hyperkalemia, hypotension, allergy, etc.).<\/span><\/div>\n
\u2022 Use standardized drug codes (RxNorm or equivalent) for digital registry entry.<\/span><\/div>\n
\u2022 These variables represent the four pillars of GDMT aligned with ESC EORP HF-III and AHA GWTG-HF datasets.<\/span><\/div>\n
<\/div>\n
\u20079.\u2060 \u2060Device Therapy<\/div>\n
\u2022 ICD (Y\/N)\u2003CRT (Y\/N)\u2003If No \u2192 Reason (Cost \/ Access \/ Not Eligible)<\/span><\/div>\n
<\/div>\n
10.\u2060 \u2060Discharge Plan<\/div>\n
\u2022 Medications reconciled (Y\/N)<\/span><\/div>\n
\u2022 Education provided (Y\/N)<\/span><\/div>\n
\u2022 Follow-up \u2264 14 days (Y\/N)<\/span><\/div>\n
\u2022 Referral to HF Clinic (Y\/N)<\/span><\/div>\n
<\/div>\n
11.\u2060 \u2060Outcomes(Each recorded as a separate field \u2014 enabling standardized national reporting. )<\/div>\n
\u2022 In-hospital mortality (Y\/N)<\/span><\/div>\n
\u2022 Length of stay (days)<\/span><\/div>\n
\u2022 30-day readmission (Y\/N)<\/span><\/div>\n
\u2022 1-year mortality (Y\/N)<\/span><\/div>\n
1-year mortality (Yes\/No): recorded at 12-month follow-up to indicate patient survival status after hospital discharge.<\/div>\n
<\/div>\n
Notes for Use<\/div>\n
\u2022 All numeric entries auto-validated against reference ranges.<\/span><\/div>\n
\u2022 Mandatory fields highlighted in color.<\/span><\/div>\n
\u2022 Information came from updates and communications with AHA \/ ESC<\/span><\/div>\n
<\/div>\n
The registry is designed to connect automatically with hospital systems using global data standards (HL7\/FHIR) and follows key definitions from ESC and AHA registries to keep information accurate, compatible, and internationally aligned.<\/div>\n","protected":false},"excerpt":{"rendered":"

National Heart Failure Registry (NHFR-JO) \u2013 Data Entry Form (Core Fields) National Heart Failure Transplantation Taskforce -JCS \u20071.\u2060 \u2060Patient Identification \u2022 Registry ID \u2022 Hospital \/ Center Name \u2022 Admission Number \u2022 Date of Admission \/ Date of Discharge \u20072.\u2060 \u2060Demographics \u2022 Age (years) \u2022 Sex (M \/ F) \u2022 Nationality \/ Residency \u2022 Smoking […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9214","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9214"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9214\/revisions"}],"predecessor-version":[{"id":9215,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9214\/revisions\/9215"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}